KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.

KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.

Mutations in KRAS, NRAS, and BRAF (RAS/BRAF) genes are the main predictive biomarkers for the response to anti-EGFR monoclonal antibodies (MAbs) targeted therapy in metastatic colorectal cancer (mCRC). This retrospective study aimed to report the mutational status prevalence of these genes, explore...

Full description

Saved in:
Bibliographic Details
Main Authors: Hector Eduardo Sanchez-Ibarra, Xianli Jiang, Elena Yareli Gallegos-Gonzalez, Adriana Carolina Cavazos-González, Yenho Chen, Faruck Morcos, Hugo Alberto Barrera-Saldaña
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0235490&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items